Thalidomide- and Lenalidomide-Associated Thromboembolism Among Patients With Cancer
Authors:
- Charles L. BennettCBCharles L. Bennett
- Cara AngelottaCACara Angelotta
- Paul R. YarnoldPYPaul R. Yarnold
- Andrew M. EvensAEAndrew M. Evens
- Jeffrey A. ZonderJZJeffrey A. Zonder
- Dennis W. RaischDRDennis W. Raisch
- Paul RichardsonPRPaul Richardson
- 6 December 2006
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA
- Vol. 296 (21) , 2555-2560
Abstract
To the Editor: The immunomodulatory drugs thalidomide and lenalidomide recently received US Food and Drug Administration approval for the treatment of multipleKeywords
This publication has 3 references indexed in Scilit:
- Thrombotic complications in patients with newly diagnosed multiple myeloma treated with lenalidomide and dexamethasone: benefit of aspirin prophylaxisBlood, 2006
- Lenalidomide and Venous Thrombosis in Multiple MyelomaNew England Journal of Medicine, 2006
- Thalidomide-associated deep vein thrombosis and pulmonary embolismThe American Journal of Medicine, 2002